JESSICA LAURIA: Open Payments
NPI 1801370473 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,669 in 141 payments from 21 companies in 2025. Trend: 2023 $2,048 · 2024 $2,478 · 2025 $2,669
Food & beverage: $2,475Education: $194
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $698 |
| ABBVIE INC. | 29 | $346 |
| GENZYME CORPORATION | 11 | $244 |
| UCB, Inc. | 10 | $240 |
| Novartis Pharmaceuticals Corporation | 24 | $232 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $144 |
| SANOFI-AVENTIS U.S. LLC | 1 | $96 |
| Arcutis Biotherapeutics, Inc. | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, SPEVIGO, COSENTYX, SKYRIZI, ILUMYA.
Industry payments across MI — which companies pay providers there.
